HIV status of TB patients in Suhum Municipal stratified by age group. by Haruna M. Salisu (12988084)

Subjects:

Data for Figs 1–3. by Cindy Leung Soo (14509700)

Subjects:

Data from: "Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts" by Aviva Geretz (10766141)

“…Altogether, scRNA-seq analyses reveal that monocyte <i>IL1B</i> expression could decrease HIV-1 proviral reservoirs in individuals initiating ART during acute infection.…”

Plasma IgG concentrations to V1V2 antigens associated with RV144 vaccine efficacy. by LaTonya D. Williams (3140490)

Subjects:

Primary and exploratory statistical analysis: comparison of binding antibody multiplex assay (BAMA) total IgG and IgG1 response magnitudes at RV144 week 26 versus RV305 week 2, RV3... by LaTonya D. Williams (3140490)

Subjects:

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases IgG and IgG1 breadth. by LaTonya D. Williams (3140490)

Subjects:

Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG3 response magnitudes at RV144 week 26 versus RV305 week 2 and RV305 week 2 versus RV305 week... by LaTonya D. Williams (3140490)

Subjects:

Lack of RSC3-reactive CD4 binding site IgG antibodies elicited in RV144 and RV305. by LaTonya D. Williams (3140490)

Subjects:

Longitudinal YU2 gp120 WT-reactive CD4i IgG binding antibodies elicited in RV144 and RV305 (related to Fig 1). by LaTonya D. Williams (3140490)

Subjects:

Primary statistical analysis: comparison of binding antibody multiplex assay (BAMA) IgG4 response magnitudes at RV144 week 26 versus RV305 week 2 and RV305 week 2 versus RV305 week... by LaTonya D. Williams (3140490)

Subjects:

IgG binding magnitudes and response rates to vaccine-matched linear epitopes at RV305 week 2 and week 26. by LaTonya D. Williams (3140490)

Subjects:

Low frequency IgG2 and lack of IgA2 induced in RV305. by LaTonya D. Williams (3140490)

Subjects:

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases breadth of Env-specific IgG response. by LaTonya D. Williams (3140490)

Subjects:

ELISA plasma IgG subclass (IgG1-IgG4) binding antibody responses against HIV gp120 A244gD, gp70V1V2 92TH023 scaffold, and gp70 CaseA2 scaffold proteins. by LaTonya D. Williams (3140490)

Subjects:

Delayed boost increases IgG4 and IgA1. by LaTonya D. Williams (3140490)

Subjects:

Fold change in humoral and cellular response magnitudes from RV305 week 2 to week 26. by LaTonya D. Williams (3140490)

Subjects:

Delayed boost lowers IgG3. by LaTonya D. Williams (3140490)

Subjects:

Durability of IgG3 responses. by LaTonya D. Williams (3140490)

Subjects:

Linear epitope mapping of RV305 plasma. by LaTonya D. Williams (3140490)

Subjects:

Antibody-dependent cellular cytotoxicity (ADCC) activity reported as AUC. by LaTonya D. Williams (3140490)

Subjects: